Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Toriumi, Ren
11  Ergebnisse:
Artikel (Online) X
Personensuche X
?
1

Therapeutic efficacy and safety of biweekly administration ..:

Nakagawa, Ryunosuke ; Izumi, Kouji ; Toriumi, Ren...
Japanese Journal of Clinical Oncology.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Bone Turnover Markers, n-Terminal Propeptide of Type I Proc..:

Kano, Hiroshi ; Izumi, Kouji ; Nakagawa, Ryunosuke...
Biomedicines.  12 (2024)  2 - p. 292 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Does radical cystectomy have a better prognosis than bladde..:

Nakagawa, Ryunosuke ; Izumi, Kouji ; Toriumi, Ren...
International Journal of Urology.  31 (2024)  6 - p. 628-636 , 2024
Link: https://doi.org/10.1111/..
 
?
4

Comprehensive analysis of perioperative hypotension in phot..:

Nohara, Takahiro ; Takimoto, Atsuya ; Shinzawa, Rei...
International Journal of Urology.  31 (2024)  8 - p. 891-898 , 2024
Link: https://doi.org/10.1111/..
 
?
5

Decreased febrile neutropenia during inpatient chemotherapy..:

Toriumi, Ren ; Yaegashi, Hiroshi ; Kadomoto, Suguru...
Cancer Science.  114 (2022)  1 - p. 201-210 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Suppression of androgen receptor signaling induces prostate..:

Kano, Hiroshi ; Izumi, Kouji ; Hiratsuka, Kaoru...
Cancer Science.  114 (2022)  4 - p. 1479-1490 , 2022
Link: https://doi.org/10.1111/..
 
?
7

Ischemic proctitis after low‐dose‐rate brachytherapy using ..:

Toriumi, Ren ; Yaegashi, Hiroshi ; Sakurai, Takayuki...
IJU Case Reports.  5 (2022)  4 - p. 237-240 , 2022
Link: https://doi.org/10.1002/..
 
?
8

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Cas..:

Iwamoto, Hiroaki ; Izumi, Kouji ; Nakagawa, Ryunosuke...
Biomedicines.  10 (2022)  10 - p. 2369 , 2022
Link: https://doi.org/10.3390/..
 
?
9

Usefulness of serum CCL2 as prognostic biomarker in prostat..:

Iwamoto, Hiroaki ; Izumi, Kouji ; Nakagawa, Ryunosuke...
Japanese Journal of Clinical Oncology.  , 2022
Link: https://doi.org/10.1093/..
 
?
10

Long response duration to pembrolizumab in metastatic, cast..:

Yoshida, Tsukasa ; Yaegashi, Hiroshi ; Toriumi, Ren...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
11

The design and synthesis of novel orally active inhibitors ..:

Palanki, Moorthy S.S. ; Erdman, Paul E. ; Ren, Minghuan...
Bioorganic & Medicinal Chemistry Letters.  13 (2003)  22 - p. 4077-4080 , 2003
Link: https://doi.org/10.1016/..
 
1-11